Concepedia

Angela M. Siesky

AM

11

Publications

1.9K

Citations

11

H-Index

2002

Active since

Affiliations

Eli Lilly (United States)(Current)

Ionis Pharmaceuticals (United States)

Indiana University – Purdue University Indianapolis

Angela M. Siesky is an author at Eli Lilly (United States) specializing in metabolism, medicine, and health sciences.

Top concepts

Publications per year

2002–2016

11

Publications

11

Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance

William L. Holland, Joseph T. Brozinick, Liping Wang et al. · Cell Metabolism · 2007 · 1.2K citations · Full text

, , +11

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky et al. · Journal of Clinical Investigation · 2004 · 210 citations · Full text

Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides

Merrill D. Benson, Barbara Kluve‐Beckerman, Steven R. Zeldenrust et al. · Muscle & Nerve · 2006 · 146 citations

Acute‐Phase Serum Amyloid A as a Marker of Insulin Resistance in Mice

Ludger Scheja, Barbara Heese, Heike Zitzer et al. · Journal of Diabetes Research · 2008 · 89 citations · Full text

, , +20

Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice

Daniel A. Briere, Xiaoping Ruan, Christine C. Cheng et al. · PLoS ONE · 2015 · 74 citations · Full text

, , +15

Rows per page

1–5 of 11